CDSCO approval granted for this game changer Eye Drop

Last Updated on September 30, 2024 by The Health Master

CDSCO approval

Entod Pharmaceuticals, a leading pharmaceutical company based in Mumbai, has received a significant CDSCO approval from the Central Drugs Standard Control Organisation (CDSCO) to commercialize PresVu, a revolutionary treatment for presbyopia.

This marks a major breakthrough for millions of Indians struggling with this age-related vision condition.

What is Presbyopia?

Presbyopia is a common eye condition that affects people over 40 years old.

It causes a gradual loss of near vision due to the hardening of the eye’s natural lens, making it difficult to focus on close objects like reading materials or smartphones.

This can significantly impact daily activities and quality of life.

PresVu: A New Dawn for Presbyopia Management

PresVu is the first-of-its-kind eye drop solution in India specifically designed to address presbyopia.

It offers a convenient and potentially life-changing alternative to traditional methods like reading glasses.

• Swift Relief: Clinical trials conducted in India and the US have shown that PresVu can improve near vision within minutes of application.
• Long-Lasting Effects: The benefits of PresVu can last up to six hours, providing sustained relief throughout the day.
• Suitable for Mild to Moderate Presbyopia: PresVu is designed to be particularly effective for individuals aged 40 to 55 with mild to moderate cases of presbyopia.

Empowering Individuals and Advancing Eye Care

Entod Pharmaceuticals is committed to making a positive impact on eye care in India. With PresVu, they aim to:

• Reduce Reliance on Reading Glasses: PresVu offers a potential alternative to reading glasses, promoting independence and reducing reliance on corrective eyewear.
• Affordable Accessibility: Entod is dedicated to manufacturing PresVu at a competitive price, ensuring affordability and accessibility for all segments of society.
• Redefining Eye Care in India: The CDSCO approval of PresVu signifies a significant step forward in Entod’s mission to revolutionize eye care solutions in India.

Looking Ahead

The launch of PresVu is a promising development for millions of Indians coping with presbyopia.

This innovative eye drop solution has the potential to improve near vision, enhance daily activities, and empower individuals to regain visual clarity and independence.

With its focus on affordability and accessibility, PresVu could redefine the way presbyopia is managed in India.

Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.

For informative videos by The Health Master, click on the below YouTube icon:

• USFDA approval granted for Lamotrigine Extended-Release Tablets USP
  October 5, 2024
• Nutraceutical Industry seeks separate Regulatory Agency
  October 5, 2024
• Boosting Drug Regulatory Efficiency: DCC recommends for Training and Development
  October 4, 2024
• CDSCO Gains Global Recognition: Milestone for Indian Medical Device Industry
  October 3, 2024
• USFDA approval granted for Cephalexin tablets
  October 2, 2024
• DCC: A Call for Safe and Responsible Drug Disposal
  September 30, 2024

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

For informative videos on consumer awareness, click on the below YouTube icon: